Collection, processing and testing of bone, corneas, umbilical cord blood and haematopoietic stem cells by European Blood Alliance members

Abstract

Estimated percentages of tissue and cell banking covered by EBA member blood banks as a proportion of all collections of each individual country varied markedly. There were also major differences in the amounts of products collected and discarded and in proportions tissues provided for grafting. However, discarding of certain collections also reflects the practice of increasing the likelihood of the very best units being used for transplantation. Harmonization of possible practices should focus on matching supply with demand and on identifying the most efficient operators. This could allow for the development of practices for minimizing unnecessary collections.

Umbilical cord blood CD34+ stem cells and other mononuclear cell subtypes processed up to 96 h from collection and stored at room temperature maintain a satisfactory functionality for cell therapy

“…Until now, (December 2013) a total of 27·538 UCB units were collected but only 17·100 were cryopreserved (rejection rate of 38%). This is keeping with data reported from several countries all over the world . Only 167 units were transplanted (Brasilcord December 2013).…”

“…0Á007 (0Á001-0Á02) 0Á008 (0Á001-0Á05) 0Á003 (0Á00-0Á02) 0Á004 (0Á001-0Á02) [31][32][33]. Only 167 units were transplanted (Brasilcord December 2013).…”

The European Hematology Association Roadmap for European Hematology Research: a consensus document

“…286 Achievements of transfusion medicine (non-remunerated donors, good manufacturing practice, traceability, and hemovigilance) can support quality management of new cellular products for immunotherapy and repair treatment. 287 …”